SCRT VS LCRT Followed by PD-L1 Inhibitor Plus CAPEOX as TNT in Patients With LARC

NCT07284992 · clinicaltrials.gov ↗
PHASE2
Phase
RECRUITING
Status
208
Enrollment
OTHER_GOV
Sponsor class

Conditions

Interventions

Sponsor

Shandong Provincial Hospital